SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Amgen Inc. (AMGN)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1906 112 0 AMGN
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1356The stock has given up pretty much all of its gain from the recent patent news. tuck-1/24/2007
1355A bit more color on the Bear Stearns report: notablecalls.blogspot.com Cheers,tuck-1/22/2007
1354>>Amgen rises on optimism it will win patent case Mon Jan 22, 2007 9:35am tuck-1/22/2007
1353Decision may alter biotech industry. Article on MedImmune decision by the SupremJGoren-1/11/2007
1352Erbitux CRYSTAL Study Hits PFS Endpoint in First-Line CRC: investorshub.com AMDewDiligence_on_SI-1/10/2007
1351you are right, i think it is too big to generate conversation here in general anmopgcw-1/6/2007
1350This is interesting to watch, aside from the patent issue. Can cera get 4-wk dokeokalani'nui-1/5/2007
1349Color on Bear Stearns upgrade: >>Amgen Up on Competition Assessment Thurstuck-1/4/2007
1348>>Partners HealthCare cutting anemia drug doses 12/28/2006 BOSTON (AP)--tuck-12/28/2006
1347ML on IMCL/AMGN: Erbitux sales declined as Vectibix share grew Based on NDC dattom pope-12/27/2006
1346Amgen gets some bad more bad PR relating to overdosing of EPO: investorshub.comtuck-12/26/2006
1345EliseWang has left Citigroup Investment Research. As a result, we are discontinumopgcw-12/19/2006
1344Thanks. Until I can assess the odds of CERA getting an approvable, I'll writuck-12/15/2006
1343Merrilll: CERA Delay should boost AMGN Roche announced a 3 month delay to its Ftom pope-12/15/2006
1342>>FDA Extends Review Of Roche Anemia Drug By PETER LOFTUS December 15, 20tuck-12/15/2006
1341>>Amgen Announces $5 Billion Stock Repurchase Plan Wednesday December 13, tuck-12/13/2006
1340AMG 531 news from ASH: Message 23095830 Cheers, Tucktuck-12/12/2006
1339Merrill. Quite a range. (Neutral) AMGN Could Trade Between $66 and $88 on Feb. tom pope-12/11/2006
1338Yeah, and thanks for the notes. It does look as if I didn't assess the immetuck-12/8/2006
1337not a buyer or seller here, dont think it is cheap nor expensive, and i agree itmopgcw-12/8/2006
1336gs: What"s changed Amgen?s EVP of Global Commercial Operations, Mr. Georgemopgcw-12/8/2006
1335gs; 52-Week Range US$81-64 YTD Price Change -12.31% Market Cap US$81.5bn EPS mopgcw-12/8/2006
1334gs; 52-Week Range US$81-64 YTD Price Change -11.37% Market Cap US$82.4bn EPS mopgcw-12/8/2006
1333Well, since then, possible epo overuse has been questioned all the way up to Contuck-12/8/2006
1332mstar; Analyst Note 10-24-2006 We didn't see a lot of surprises in Amgen'mopgcw-12/8/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News